This website is funded by Jazz Pharmaceuticals, and contains promotional content. This content is intended for Healthcare Professionals only.
WELCOME TO THE DEFITELIO®(Defibrotide) PORTAL
THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY
This website contains promotional information on Defitelio▼ (defibrotide) and has been developed in-line with EU marketing authorisation. Please consult local prescribing information for further information.
By entering this site, you are confirming that you are a healthcare professional within your selected country.
Adverse events should be reported. Healthcare Professionals are asked to report any suspected adverse events via their national reporting system. For the UK, reporting forms and information can be found at yellowcard.mhra.gov.uk, or search for Yellow Card MHRA in the Google Play or Apple App Store. Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com
▼ - This medicinal product is subject to additional monitoring
Date of Preparation: August 2023
© 2022 Jazz Pharmaceuticals Inc., a subsidiary of Jazz Pharmaceuticals plc, all rights reserved